NASDAQ NMS - GLOBAL MARKET · CSBR
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Champions Oncology Inc

Champions Oncology Inc

Life Sciences Tools & Services
$4.96
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
CSBR
Champions Oncology Inc
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

75/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CSBR moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CSBR catalysts
About Champions Oncology Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
1994
Employees
214
Country
US

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$4.96
Last session
Day high
$4.96
Last session
Day low
$4.96
Last session
Previous close
$4.96
52W high
$8.30
-40.24% from high
52W low
$4.94
1% of range
Market cap
$68.9M
P/E
17.71×
EPS
$0.2800
Beta
-0.04
Shares out
13.9M
Avg volume
10.6K
VWAP
$4.96
Last session
Price history computed in-house
1W
-1.39%
1M
-19.08%
3M
-17.12%
1Y
-34.99%
YTD
-28.22%
SMA 50 $5.78 · below
SMA 200 $6.17 · below
52W position 1%

CSBR overview

Veridion Score
75
Registered · 2026-08-21
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CSBR.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CSBR Form 4 filings
Public disclosures

Congress activity in CSBR

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for CSBR in the cached public ledger.

Federal contracts

CSBR contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CSBR in this window.
Lobbying spend

CSBR lobbying filings, year to date.

Registered lobbying filings matched to Champions Oncology Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CSBR in this window.
Loading news for CSBR
Analyst ratings
Sovereign unlock shows live analyst consensus for CSBR.
Options
Sovereign unlock shows live options positioning for CSBR.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.